We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NLSP NLS Pharmaceutics Ltd

0.00 (0.0%)
Dec 05 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.54
Ask Price 0.57
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
NLS Pharmaceutics Ltd NLSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.5505 19:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.26 - 1.88
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.5505 USD

NLS Pharmaceutics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.85M - - - -108.44
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NLS Pharmaceutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NLSP Message Board. Create One! See More Posts on NLSP Message Board See More Message Board Posts

Historical NLSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3860.7270.3850.60454925,575,0970.164542.62%
1 Month0.720.7270.260.57943311,645,709-0.1695-23.54%
3 Months0.851.0150.260.5990921598,471-0.2995-35.24%
6 Months0.971.530.260.7207097368,383-0.4195-43.25%
1 Year0.951.880.260.8240647221,455-0.3995-42.05%
3 Years2.99657.350.262.79848,370-2.45-81.63%
5 Years2.99657.350.262.79848,370-2.45-81.63%

NLS Pharmaceutics Description

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |